Newsroom

Recent News

• Medical College of Wisconsin Public Statement on Masks and COVID-19

  Aug 7, 2020

  We must use the limited tools we have today to slow the spread of the COVID-19 virus and minimize the damage it causes to individuals, our communities, and our economy.

• Study Reveals Potential New Therapy for Interstitial Lung Disease in Patients with Immunodeficiency

  Aug 3, 2020

  Research published recently in the Journal of Allergy and Clinical Immunology highlights the successful treatment of an interstitial lung disease in children with common variable immunodeficiency

• Medical College of Wisconsin to Study Brain Changes Following Loss of Loved One to Prevent Grief-Related Complications

  Jul 28, 2020

  MCW has received a five-year, $2.6 million grant from the National Institutes of Health (NIH) National Institute of Mental Health (NIMH) to study complicated grief symptom trajectory and prolonged grief disorder.

• Medical College of Wisconsin-Central Wisconsin Launches Training Program for Rural and Hmong Prospective Medical Students

  Jul 14, 2020

  The Advocates in Medicine Pathway (AMP) will support the professional development of 10 rural and underrepresented in medicine undergraduate students enrolled at the University of Wisconsin-Stevens Point at Wausau each year.

• Study of Social Determinants Reveals Financial Hardships Take Most Significant Toll on Health in Elderly Adults with Diabetes

  Jul 13, 2020

  A recent study led by MCW researchers was published in the scientific journal Diabetes Care and highlights some of the social factors that influence outcomes for adults with diabetes, several of which are significant risk factors for COVID-19.

• National Cancer Research Association Recognizes Local Researcher with Team Science Award

  Jun 29, 2020

  The American Association for Cancer Research has recognized Janet S. Rader, MD as a contributing team member of the Cancer Genome Atlas (TCGA) project team.

• Researchers to Test Innovative Gene Therapy in Hemophilia-A Clinical Trial

  Jun 16, 2020

  Patients are now able to participate in a phase I, first-in-human FDA approved clinical trial seeking a potential long-term treatment for Severe Hemophilia-A.

View More News